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Abstract 
PURPOSE:  To report the incidence and sequelae of migration of the Nellix® endoprothesis 
following endovascular aneurysm sealing (EVAS). 
METHOD:  A review was performed of the follow-up imaging of all EVAS patients in a 
University Hospital endovascular programme who had a minimum follow-up of one year.  Using 
the first post-operative and latest follow-up CT scans, the distances between the proximal and 
distal borders of the stent-grafts relative to reference vessels were measured using a previously 
validated technique.  Device migration was based on previously established criteria and defined 
as any stent-graft movement of ≥ 4 mm related to a predefined reference vessel.  Device 
movement in a caudal direction was given a positive value (+) whereas movement in a cranial 
direction was denoted by a negative sign (-). 
RESULTS:  18 patients (35 stent-grafts) were eligible for inclusion in this retrospective review.  
The mean (SD; range) pre-operative AAA diameter and aortic neck length were 57 (5; 50 to 67) 
mm and 30 (16; 6 to 62) mm, respectively.  Proximal migration, according to study definitions, 
was identified in six stent-grafts (17%), all in a caudal direction.  At one year the mean (SD; 
range) proximal migration distance was +6.6 (1.6; +4.7 to +9.2) mm.  Migration occurred in a 
single stent-graft in four patients and bilaterally in one.   Distally, there were no cases of 
migration. 
CONCLUSIONS: Proximal migration of the Nellix® endoprosthesis does occur and in our series 
was without any sequelae. Further investigations into the long-term positional stability of the 
Nellix® device are required together with a more thorough understanding of the aetiology and 
consequences of migration. 
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Introduction 
The Nellix® endoprosthesis (Endologix Inc, Irvine, California, USA) has been used to treat 
numerous patients with abdominal aortic aneurysms (AAA) [1-3].  The use of a sac-anchoring 
endograft such as the Nellix® has brought a change in the approach to aneurysm exclusion.  
The Nellix® device consists of balloon expandable stents surrounded by endobags that are filled 
with a polymer thereby sealing the aneurysm.  This change in approach to AAA therapy has been 
termed endovascular aneurysm sealing or EVAS.  By sealing the aneurysm sac instead of 
excluding it with only proximal and distal fixation, the risk of stent migration and endoleaks has 
been reported to have theoretically diminished [4, 5]. 
Complications have, however, been reported following implantation of the Nellix® 
device.   Böckler and colleagues, in a recent multicentre case series analysis, reported type 1a, 
type 1b and type II endoleaks in a small number of patients [3].  Authors in the same publication 
documented the need for aneurysm-related interventions in 15 patients (9%) but there was an 
absence of any aneurysm ruptures or open surgical conversions.  
This report aims to investigate early migration of the Nellix® endoprosthesis in patients 
with a minimum follow-up of 12 months. 
Methods 
Study Design and Technique 
EVAS was introduced into our practice in December 2013.  Suitability for EVAS was 
determined by a team of clinicians using arterial phase computed tomography (CT) and 
confirmed at a weekly multidisciplinary team review of all prospective elective patients for AAA 
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repair.  The technique of EVAS has been described extensively within the literature [1, 6, 7].  
This project fell within a programme of studies evaluating EVAS at our institution and as such 
formal ethics committee approval was not required.  Patient informed consent was obtained for 
the EVAS procedure and this included an understanding that procedural outcomes would be 
evaluated and reported accordingly.   
Follow-up Imaging Protocol 
Our follow-up protocol includes post-operative imaging by conventional abdominal radiography 
on day 1, duplex ultrasound and arterial phase CT at 1 month, followed by yearly abdominal 
radiographs, duplex scans, and arterial phase CT except in patients with significant renal 
impairment.  All CT acquisitions conformed to a standard follow-up protocol and CT data were 
reconstructed using the thinnest available slice (≤2 mm) prior to review. 
Study Measurements 
For inclusion, all patients were required to have had a baseline (first) post-operative CT scan 
(within six weeks following device implantation) and at least one additional CT scan (minimum 
of 12 months from the initial implantation procedure) available in DICOM (Digital Imaging and 
Communication in Medicine) format. 
 Our methods for assessing and defining stent-graft migration are based on previous 
experimental work [8] and have been used to report migration in two clinical studies [9, 10].  
Previous experimental work included an assessment of the bias (difference between true 
migration and the CT assessment) and both intra- and inter-observer variability [8].  Migration 
was defined as cranial or caudal movement of the stent-graft, relative to a vascular landmark of 
≥4 mm. 
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 In order to quantify stent-graft migration a central luminal line (CLL) was created from 
CT data on a computer workstation (Carestream Health Inc, Rochester, NY, USA).  
Confirmation that the CLL ran through the central luminal channel of the aorta and common iliac 
arteries (CIA) was obtained by visual inspection of the reconstructed images.  For proximal 
migration the native vascular reference point was the superior mesenteric artery (SMA). The 
distance between the inferior border of the SMA and the first appearance of both the left and 
right stent-grafts was measured separately (Fig 1).  At the distal margins the common iliac artery 
bifurcation was used as the reference point (Fig 2). Curved length measurements allowed the 
measurement from the proximal stent-grafts to the SMA and from the distal stent-grafts to the 
common iliac artery bifurcation on the 1st post-operative CT scan.  Each CLL measurement was 
then compared with the same measurement on the one year CT scan. Measurement differences 
between the 1-month and 1-year CT scan, for the same anatomical location, were used to 
determine if there was device migration. Caudal migration was indicated by a positive value and 
cranial with a negative value.  Measurements were recorded electronically to 1/10 of a 
millimetre. 
Based on the CLL measurements any patient meeting our definition of migration was 
subjected to further scrutiny (Fig 3).  This included visual analysis of the reconstructed aortic 
segment from which specific landmarks were identified within the aortic wall such as 
calcification. These images, in addition to the CLL data, were assessed by two observers 
(authors) in order to confirm whether the device had migrated.  In addition to migration 
assessment the study group was subject to further evaluations which included review of follow-
up imaging records and clinical notes.   With respect to this study, the aortic neck was defined as 
the distance from the lower margin of the most caudal renal artery to a point distally where the 
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lumen diameter increases by a maximum of 20 %, after which point it was considered to be the 
start of the aneurysm. 
Statistical Analysis 
SPSS 20.0 (IBM Corp, Armonk, New York) was used for the statistical analysis. Variables were 
summarised as mean (standard deviation; range) in the cases of distributions that were 
approximately normal.  The median (inter-quartile range; range) were reported if the data were 
not approximately normally distributed.  Categorical data were summarised as frequencies 
together with their respective percentages. 
 
 
 
Results 
18 patients were treated by EVAS at our institution between December 2013 and August 2014 
and were eligible for inclusion in this retrospective review.  Additional patients had undergone 
EVAS but either their follow-up was not past one year or that they did not have two follow-up 
CT scans available.   For included patients the mean (SD; range) age was 80 (7; 69 to 91) years, 
10 (56%) were men and the mean (SD; range) maximum preoperative AAA diameter was 58 (5; 
50 to 67) mm.  Of the 18 patients the mean (SD; range) neck length was 30 (16; 6 to 62) mm.  
Two Nellix® devices were deployed in two patients with aortic necks less than 10 mm in length.  
Based on the Manufacturer’s Instructions for Use (IFU)[11] these cases were ‘off-label’ but 
there were other areas within the infrarenal aorta which were deemed suitable for sealing.  17 
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(94%) patients had EVAS using paired stent-grafts deployed into both the left and right common 
iliac arteries, a single patient had a single ‘off-label’ aorto-uniiliac (AUI) device implanted.  
Mean (SD; range) follow-up was 13.5 (0.8; 12.3 to 15.1) months.  Maximum aneurysm diameter 
remained relatively stable during follow-up, the mean (SD; range) change was 1.1 (2.8; -3.0 to 
7.0) mm.     
Device migration 
Based on the analysis of 36 follow-up CT scans the assessment of proximal and distal migration 
was possible in all patients.  A total of 35 stent-grafts were assessed for proximal migration (one 
AUI), 6 stent-grafts (17%) were determined to have migrated mean (SD; range) +6.6 (1.6; +4.7 
to +9.2) mm with respect to their initial implanted position.  Proximal migration was present in a 
single stent-graft in four patients and a further patient exhibited proximal migration in both stent-
grafts (Table I).  One of the single stent-graft migrations was in a patient with an off-label AUI 
device and migration of both stent-grafts occurred in a patient with a 6 mm aortic neck.  Distally, 
there were no cases of stent-graft migration identified according to study definitions. 
Discussion 
We have identified five patients who on post-EVAS surveillance imaging demonstrated CT 
evidence of proximal device migration (≥ 4 mm).  All device migrations occurred at the proximal 
margins and movements ranged from 4.7 to 9.2 mm in a caudal direction.  Based on our cohort 
of 18 patients this equates to a 28% migration rate.  To our knowledge, this is the first report of 
migration of Nellix® devices.  This may be explained by the novelty of EVAS and the very 
small number of cases reported in the literature, almost invariably with short follow-up periods.  
Furthermore, expert commentary within the literature suggests that attachment site fixation 
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issues are unlikely to be a complication following EVAS [4,5] and, therefore, may not be 
proactively scrutinised during follow-up.  It is important to note that there are several definitions 
of device migration within the literature (11, 12).  The most widely used is from the Society for 
Vascular Surgery/International Society for Cardiovascular Surgery but this over 15 years old and 
was developed in an era of standard infra-renal EVAR and single detector row CT technology.  
Within these standards a larger migration definition (≥10 mm) is recommended and if applied to 
this study it would have generated a zero rate of migration.  With the increasing complexity of 
endovascular aortic procedures and newer technologies e.g. EVAS attracting widespread clinical 
use we would argue for a more conservative definition.  Our definition chosen for this study had 
a separate validation and reliability study published (8) and has also been used to report 
migration in two recent clinical publications (9, 10).         
The Nellix® device does not have active fixation but device stability is achieved through 
support from the stent/endobag complex occupying all of the available space.  Narrowing in the 
infra-renal neck and the aortic bifurcation supports the cured polymer within the endobags and 
resists migration.  However, long-term stability requires that the aorta and the iliac arteries do 
not dilate, above or below the endobags and that the volume and shape of the unpressurised 
aneurysm and thrombus do not change.  If either situation occurs, then this may provide one 
possible explanation as to why there are cases of proximal migration following EVAS.  The 
Nellix® device experiences distraction forces similar to a standard EVAR device (13), but does 
not have the fixation through barb engagement or the radial force associated with self-expanding 
stents.  These distraction forces may also work laterally and drive the endobag through the sac 
thrombus, thereby facilitating migration.  Such bowing of the stent and endobag may be 
associated with a change in appearance of the Nellix® within a sac of equal volume or equal 
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thrombus volume.  This will be studied as part of future research.  If the endobags migrate then 
the relationship between them and the aortic wall established at deployment is lost.  This may 
result in a flow channel developing alongside the endobag within the aortic neck with a 
subsequent endoleak occurring.  Although this was not seen in our series, those patients in whom 
there has been migration identified require close observation.  The series reported reflects 
migration of the stents and not the endobags within the aorta.  Visualisation of the chromium-
cobalt stents is very clear and, therefore, allows accurate scrutiny.  The endobags, however, are 
not as clearly defined and it is less reliable to assess their movement.  Bench observations have 
suggested that some independent movement of the stent in relation to the endobag is possible.  
The precise extent of this is not clear and would need further investigation.  Migration of the 
stent of greater than 4 mm as reported in over a quarter of this series is very likely to represent 
some migration of the endobag also, albeit without loss of seal in the short-term.  It is not clear 
whether these initial movements of the Nellix® are a period of stabilisation or whether 
movements are likely to be progressive.   
Caudal migration within the proximal sealing zone after EVAS is of concern. The 
manufacturers IFU (14) states that the neck should be at least 10 mm in length with variation in 
diameter no more than 20%.  Applying these criteria strictly rendered some of our patients 
outside of the IFU, whilst there was a secondary neck within which sealing could be anticipated. 
This is evidenced by the fact that in patient 17 the neck was deemed 6 mm in length and yet, 
despite a 9 mm caudal migration, there was no endoleak.  This was due to a conical secondary 
neck that did not fulfil IFU criteria but did facilitate sealing.  It is generally accepted that 
adherence to IFU reduces complications but the authors recognise that there are variations in 
aortic morphology tolerated for sealing.  Further studies, with a larger sample size and a 
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multicentre focus, are required in order to fully understand how the aneurysm morphology may 
influences migration and its possible consequences.  
Within our cohort no cases of migration have been associated with any adverse event.  It 
is also not clear why some patients experience stent-graft movement and some do not.  Small 
movements of the Nellix® system could result from aneurysm morphology changes during 
follow-up and the long-term significance is currently unknown.  Movements at the proximal 
landing zones do raise questions regarding the need for long-term follow-up in EVAS patients.  
Careful follow-up of EVAS patients is paramount in order to identify whether movements 
represent a benign settling period or whether these movements could transform into more serious 
complications.  Follow-up intervals and imaging methods are often debated when deploying 
aortic devices.  Within our practice follow-up imaging was based on the combined use of duplex 
ultrasound, CT and abdominal radiography.  Reducing the number of CT scans has accepted 
benefits including reductions in cost, radiation dose and the risk of contrast induced nephropathy.  
Review of migration cases within our series has provided some evidence that EVAS related 
migration can be identified using abdominal radiography (Fig 4).       
There were no cases of distal (iliac) migration within our cohort.  A number of factors 
could explain this including the forces acting on the distal landing zones, length of follow-up, 
level of stent-graft engagement within the common iliac artery and the overall extent of disease.  
Forces acting at the proximal landing zones are greater than those in at the distal landing and are 
in an opposite direction [15]. The length of coverage of the common iliac artery is a potential 
factor in preventing distal stent-graft migration into the aneurysm sac [16].  Iliac artery coverage 
and angulation was not assessed in this study but could have a role in preventing migration. 
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Conclusion 
Endovascular sealing is a promising technique for treating AAAs.  Early efficacy data are 
encouraging, however, the safety of this technique remains under scrutiny.  Proximal migration 
of the Nellix® endoprosthesis does occur but it is not clear whether this will translate into 
associated complications.  Further investigations into the long-term positional stability of the 
Nellix® device are required together with a more thorough understanding of the aetiology of any 
migration.   
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Legends for Figures 
 
 
Figure 1.  CT central luminal line measurements illustrating the assessment of proximal 
migration.  In this case (9) the left proximal stent-graft was 15.6 mm inferior to the superior 
mesenteric artery (SMA) on the 1-month post-EVAR CT.  At 1-year the left proximal stent-graft 
had migrated caudally by 7.1 mm and is resting 22.7 mm inferior to the SMA.   
 
Figure 2.  CT central luminal line measurements illustrating the assessment of distal migration.  
In this case (3) the left distal stent-graft was 20.2 mm superior to the common iliac artery 
bifurcation on the 1-month CT scan.  By 1-year, the left distal stent-graft was located 19.2 mm 
superior to the CIA bifurcation, with no evidence of migration.   
Figure 3.  Coronal maximum intensity projections (MIP) demonstrating the migration of both 
stent-grafts (case 17) from the 1-month post-EVAS CT scan to the 1-year post-EVAS CT scan.  
Coronal MIP images were used as part of further scrutiny in order to visually verify (within the 
research team) the existence of migration.   
Figure 4.  Lateral abdominal X-ray images at 1-month and 12-months illustrating the 
radiographic appearances of Nellix® migration.     
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Table I.  Details surrounding the six cases (five patients) of proximal stent-graft migration.   
Patient Migration Pre-operative morphology Intra-operative Follow-up 
Case 
numbe
r 
Gende
r / 
Age 
(years
) 
Locatio
n 
Distanc
e (mm) 
Neck 
Diamet
er (mm) 
Neck 
Lengt
h 
(mm) 
Neck 
Angulatio
n (o) 
Max. 
AAA 
Diamet
er (mm) 
Lumen / 
Thrombu
s volume 
(ml) 
Endoseala
nt volume 
(ml) 
Complicatio
ns 
AAA 
Diamet
er 
Change, 
mm (%) 
Complications 
Total 
(month
s) 
Early Late 
4 M (90) 
Proxim
al (Left) 
+4.7 31 62 43 58 90 / 54 75 No 6 (10) No 
No 
 
13.2 
9 F (78) 
Proxim
al 
(Right) 
+7.1 22 16 31 56 50 / 79 50 No -3 (5) No No 13.5 
12 M (71) 
Proxim
al 
(Right) 
+6.4 30 15 32 67 55 / 106 58 No -1 (2) No No 13.0 
13* F (83) 
Proxim
al (Left) 
+5.2 20 54 29 50 28 / 38 31 
Ruptured 
EIA 
0 (0) 
Paraparesi
s, NSTEMI, 
femoral 
fracture 
EIA 
stenosi
s 
12.6 
17 F (87) 
Proxim
al (Left) 
+9.2 
30 6 17 67 
102 / 
238 
88 No 5 (7) No No 13.6 
Proxim
al 
(Right) 
+6.7 
*aorto uni-iliac configuration; EIA, external iliac artery; M, male; F, female; mo, months; NSTEMI, non ST elevated myocardial infarction.  Max, maximum.   
 
 
